COVID-19

A recent study examined patient characteristics and factors affecting COVID-19 mortality in individuals with diabetes.

Eli Lilly’s BLAZE-1 study produced strong evidence that treatment with bamlanivimab plus etesvimab reduced risk of COVID-19 hospitalizations and death.

The CDC’s Advisory Committee on Immunization Practices issued updates to its interim recommendations for mRNA COVID-19 vaccines.

The Biden administration announced efforts to boost COVID-19 vaccination supply and increase transparency.

In a statement, NCPA urges the new administration to engage community pharmacies in the fight against the COVID-19 pandemic.

Here's the roundup of the latest coronavirus-related news.

A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.

In its next live webinar event, MJH Life Sciences™ COVID-19 Coalition will explore emerging mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Drug Topics interviews Naomi Lopez, director of healthcare policy at the Goldwater Institute, focusing on expanding scope of practice and COVID-19 vaccine candidates already being used in other countries.

In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.

ISMP identified the most commonly reported errors and hazards associated with the new COVID-19 vaccines.

President-elect Joe Biden revealed his COVID-19 plan, which includes a disciplined focus on vaccination efforts.

Here's the latest coronavirus-related news.

On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).

Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.

In a final briefing, OWS recommended states expand vaccination to all individuals 65 and older or those with comorbidities.

The FDA has identified 3 molecular tests that may be impacted by an emerging SARS-CoV-2 variant.

Here’s a roundup of the latest coronavirus-related news.

In a briefing on Wednesday, Dr Hanson and Dr Caliendo of the Infectious Diseases Society of America relayed the updated recommendations for COVID-19 diagnostic testing.

How will a change in administration, a vaccine for COVID-19, and other factors change the industry in the year ahead?

Moderna is upping its COVID-19 vaccine production this year, with a baseline estimation of 600 million doses for 2021.

In a statement, FDA officials recommended that all health care professionals continue to adhere to the FDA-authorized dosing and schedules of the COVID-19 vaccines.

With support from Operation Warp Speed and the National Institutes of Health, the study will evaluate the safety and efficacy of NVX-CoV2373.

Eric Levin, CEO of Scripta Insights, discusses trends that are shifting pharmacy toward delivery services and the impacts on the prescription drug market.

Stephen Schondelmeyer, PharmD, Drug Topics editorial advisory board member, discusses pharmacy highlights from 2020, and where he sees pharmacy headed in 2021.